Moderna delays norovirus vaccine readout, cites insufficient infections
read at Endpoints ↗Negative readoutNeutral
Moderna announced that its norovirus vaccine trial will not yield efficacy data this season because infection rates were lower than expected.
The company said it will open an additional trial cohort to enroll more participants and will wait for the next norovirus season to collect sufficient cases for analysis.
The delay pushes back the timeline for any potential regulatory filing and highlights the difficulty of testing vaccines for diseases with seasonal incidence.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Moderna's norovirus vaccine readout is delayed because of too few infections”
read at Endpoints ↗91 words · retrieved 4h ago
comments(0)
5-min edit window · permanent after that